Merck, Glenmark Stifled Cholesterol Drug Market, Suit Says
Merck & Co. and generics manufacturer Glenmark Pharmaceuticals Inc. were hit with a putative class action in Virginia federal court Wednesday claiming an agreement to keep a generic version of cholesterol...To view the full article, register now.
Already a subscriber? Click here to view full article